Status:
COMPLETED
Objective Quality of Life Detection Validation
Lead Sponsor:
Great Lakes NeuroTechnologies Inc.
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Parkinson Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this research study is to: * Collect data to use in the development of a standardized tool for identifying patients with Parkinson's disease (PD) who would benefit from advanced therap...
Detailed Description
The investigators aim to develop a standardized tool for identifying patients with Parkinson's disease (PD) who would benefit from advanced therapies (AT) and identify when AT recipients are in need o...
Eligibility Criteria
Inclusion
- Able to provide informed consent
- Diagnosed with PD
- Hoehn and Yahr scale I-III
- Able to travel to Great Lakes NeuroTechnologies
- Ambulatory and capable of using the Kinesia 360 system
- Able to understand and follow instructions regarding using the device
Exclusion
- Any subject that does not meet the subject selection criteria will be excluded from this study. Children will be excluded from this study due to the fact that they are unlikely to have PD. Subjects that are not capable of functioning independently or are so symptomatic as to compromise their safety will also be excluded.
Key Trial Info
Start Date :
September 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04121793
Start Date
September 20 2019
End Date
June 30 2020
Last Update
August 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Great Lakes NeuroTechnologies
Cleveland, Ohio, United States, 44131